Isaac E. Ciechanover
2016
In 2016, Isaac E. Ciechanover earned a total compensation of $10M as President and Chief Executive Officer at Atara Biotherapeutics, a 53% increase compared to previous year.
Compensation breakdown
| Bonus | $327,870 |
|---|---|
| Salary | $546,000 |
| Stock Awards | $9,134,694 |
| Other | $5,856 |
| Total | $10,014,420 |
Ciechanover received $9.1M in stock awards, accounting for 91% of the total pay in 2016.
Ciechanover also received $327.9K in bonus, $546K in salary and $5.9K in other compensation.
Rankings
In 2016, Isaac E. Ciechanover's compensation ranked 511th out of 14,075 executives tracked by ExecPay. In other words, Ciechanover earned more than 96.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 511 out of 14,075 | 96th |
Division Manufacturing | 164 out of 5,489 | 97th |
Major group Chemicals And Allied Products | 40 out of 1,895 | 98th |
Industry group Drugs | 25 out of 1,538 | 98th |
Industry Biological Products, Except Diagnostic Substances | 7 out of 279 | 98th |
Source: SEC filing on April 24, 2017.
Ciechanover's colleagues
We found two more compensation records of executives who worked with Isaac E. Ciechanover at Atara Biotherapeutics in 2016.